Organization: Health Canada
Year: 2023
Month: July
Request Number: A-2022-000451
Request Summary: Health Canada is currently reviewing an Abbreviated New Drug Submission (ANDS) seeking approval of a product containing the medicinal ingredient desmopressin acetate. Provide the name of the company who submitted the Desmopressin ANDS, which was accepted into review on or after March 1, 2022.
Disposition: Disclosed in part
Number of pages: 3